BioPharma Credit Dividends and Buybacks
Dividend criteria checks 4/6
BioPharma Credit is a dividend paying company with a current yield of 11.13% that is well covered by earnings.
Key information
11.1%
Dividend yield
7.6%
Buyback Yield
Total Shareholder Yield | 18.7% |
Future Dividend Yield | n/a |
Dividend Growth | 10.5% |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | US$0.103 |
Payout ratio | 82% |
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: BPCR has been paying a dividend for less than 10 years and during this time payments have been volatile.
Growing Dividend: BPCR's dividend payments have increased, but the company has only paid a dividend for 7 years.
Dividend Yield vs Market
BioPharma Credit Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (BPCR) | 11.1% |
Market Bottom 25% (GB) | 2.1% |
Market Top 25% (GB) | 5.9% |
Industry Average (Capital Markets) | 2.9% |
Analyst forecast (BPCR) (up to 3 years) | n/a |
Notable Dividend: BPCR's dividend (11.13%) is higher than the bottom 25% of dividend payers in the UK market (2.11%).
High Dividend: BPCR's dividend (11.13%) is in the top 25% of dividend payers in the UK market (5.88%)
Earnings Payout to Shareholders
Earnings Coverage: At its current payout ratio (81.6%), BPCR's payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: At its current cash payout ratio (83.4%), BPCR's dividend payments are covered by cash flows.